Home Newsfeeds ConocoPhillips Says It Has Seen Some Inflationary Pressures In Its Alaska Willow Project; Says Its Current Cost Estimate For Willow Project Is Between $7B-$7.5B

ConocoPhillips Says It Has Seen Some Inflationary Pressures In Its Alaska Willow Project; Says Its Current Cost Estimate For Willow Project Is Between $7B-$7.5B

– Reuters

byHappy Mohamed

February 2, 2023

1 minute read

– Reuters

FDA Pushes Decision Date For Reata’s Genetic Neuromuscular Disease Candidate

By Vandana Singh

August 9, 12:04 PM

The FDA has extended the review timeline for Reata Pharmaceuticals Inc’s (NASDAQ:RETA) marketing application seeking approval for omaveloxolone for Friedreich’s ataxia by…

RETA

Goldman Sachs Maintains Buy on EQT, Lowers Price Target to $49

By Benzinga Newsdesk

December 29, 9:19 AM

Goldman Sachs analyst Neil Mehta maintains EQT (NYSE:EQT) with a Buy and lowers the price target from $55 to $49.

EQT

Eaton FY23 EPS Outlook Of $8.04 – $8.44 Vs. $8.22 Estimate; Q1 EPS Outlook Of $1.72 – $1.82 Vs. $1.80 Estimate

By Benzinga Newsdesk

February 8, 7:34 AM

For the full year 2023, the company expects organic growth of 7-9% and adjusted earnings per share to be between $8.04 and $8.44, up 9% at the midpoint over 2022. For the first quarter of 2023, the company anticipates

ETN

Why Minerva Neurosciences Stock Is Shooting Higher Today

By Nabaparna Bhattacharya

June 28, 10:49 AM

Minerva Neurosciences, Inc (NASDAQ: NERV) are shooting higher after the company bagged a $20 million investment from Boehringer Ingelheim and Federated Hermes Kaufmann Funds via

NERV

ConocoPhillips Says It Has Seen Some Inflationary Pressures In Its Alaska Willow Project; Says Its Current Cost Estimate For Willow Project Is Between $7B-$7.5B

Related Posts

FDA Pushes Decision Date For Reata’s Genetic Neuromuscular Disease Candidate

Goldman Sachs Maintains Buy on EQT, Lowers Price Target to $49

Eaton FY23 EPS Outlook Of $8.04 – $8.44 Vs. $8.22 Estimate; Q1 EPS Outlook Of $1.72 – $1.82 Vs. $1.80 Estimate

Why Minerva Neurosciences Stock Is Shooting Higher Today